Yu‐Feng Lin

4.5k total citations
104 papers, 2.8k citations indexed

About

Yu‐Feng Lin is a scholar working on Nephrology, Cardiology and Cardiovascular Medicine and Emergency Medicine. According to data from OpenAlex, Yu‐Feng Lin has authored 104 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Nephrology, 18 papers in Cardiology and Cardiovascular Medicine and 15 papers in Emergency Medicine. Recurrent topics in Yu‐Feng Lin's work include Acute Kidney Injury Research (22 papers), Chronic Kidney Disease and Diabetes (11 papers) and Dialysis and Renal Disease Management (9 papers). Yu‐Feng Lin is often cited by papers focused on Acute Kidney Injury Research (22 papers), Chronic Kidney Disease and Diabetes (11 papers) and Dialysis and Renal Disease Management (9 papers). Yu‐Feng Lin collaborates with scholars based in Taiwan, United States and China. Yu‐Feng Lin's co-authors include Wen‐Je Ko, Hung‐Bin Tsai, Kwan‐Dun Wu, Vin‐Cent Wu, Nin‐Chieh Hsu, Yung‐Ming Chen, Chia‐Ter Chao, Huan‐Tsung Chang, Yu‐Fen Huang and Helen E. Heslop and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Yu‐Feng Lin

100 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yu‐Feng Lin Taiwan 30 803 635 507 349 315 104 2.8k
Ping Fu China 33 1.4k 1.8× 366 0.6× 1.4k 2.8× 485 1.4× 142 0.5× 178 4.9k
Wen‐Feng Fang Taiwan 31 353 0.4× 703 1.1× 746 1.5× 654 1.9× 171 0.5× 161 3.3k
Ying Yao China 30 995 1.2× 822 1.3× 918 1.8× 370 1.1× 93 0.3× 110 4.6k
Vedat Schwenger Germany 37 1.7k 2.1× 288 0.5× 523 1.0× 448 1.3× 155 0.5× 197 4.6k
Raffaele Serra Italy 34 358 0.4× 305 0.5× 643 1.3× 397 1.1× 152 0.5× 258 4.8k
Daniel Ackermann Switzerland 38 552 0.7× 324 0.5× 818 1.6× 218 0.6× 74 0.2× 134 4.3k
John T. Harrington United States 28 1.3k 1.6× 213 0.3× 543 1.1× 197 0.6× 61 0.2× 109 3.3k
Seung Seok Han South Korea 28 1.0k 1.3× 101 0.2× 310 0.6× 429 1.2× 126 0.4× 185 2.9k
Mohammadreza Ardalan Iran 33 712 0.9× 191 0.3× 850 1.7× 347 1.0× 188 0.6× 281 3.9k
Hye‐Ryun Kang South Korea 35 241 0.3× 179 0.3× 505 1.0× 260 0.7× 85 0.3× 237 4.6k

Countries citing papers authored by Yu‐Feng Lin

Since Specialization
Citations

This map shows the geographic impact of Yu‐Feng Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu‐Feng Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu‐Feng Lin more than expected).

Fields of papers citing papers by Yu‐Feng Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu‐Feng Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu‐Feng Lin. The network helps show where Yu‐Feng Lin may publish in the future.

Co-authorship network of co-authors of Yu‐Feng Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Yu‐Feng Lin. A scholar is included among the top collaborators of Yu‐Feng Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu‐Feng Lin. Yu‐Feng Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Lin, Yu‐Feng, et al.. (2024). Carbon-dot liposome–based synthesis of gold nanocatalysts for efficient reduction of 4-nitrophenol in wastewater. Sustainable materials and technologies. 40. e00896–e00896. 8 indexed citations
3.
4.
Pan, Szu‐Yu, et al.. (2024). Unveiling the enigma of acute kidney disease: predicting prognosis, exploring interventions, and embracing amultidisciplinary approach. Kidney Research and Clinical Practice. 43(4). 406–416. 2 indexed citations
5.
Hsu, Ya‐Ju, Amit Nain, Yu‐Feng Lin, et al.. (2022). Self-redox reaction driven in situ formation of Cu2O/Ti3C2Tx nanosheets boost the photocatalytic eradication of multi-drug resistant bacteria from infected wound. Journal of Nanobiotechnology. 20(1). 235–235. 32 indexed citations
6.
7.
Hsu, Nin‐Chieh, et al.. (2021). Integrated approach for multimorbid patients in a hospitalist setting: Survival analysis of a two-year prospective study. Journal of the Formosan Medical Association. 121(2). 473–481. 2 indexed citations
8.
Lin, Yu‐Feng, et al.. (2021). Reduction of breast tumor drug resistance by 2,3,5,4’-tetrahydroxystilbene for exhibition synergic chemotherapeutic effect. PLoS ONE. 16(12). e0260533–e0260533. 3 indexed citations
9.
Tsimberidou, Apostolia M., Henry Hiep Vo, Stephen Eck, et al.. (2021). T-cell receptor-based therapy: an innovative therapeutic approach for solid tumors. Journal of Hematology & Oncology. 14(1). 105 indexed citations
10.
Hsieh, Ming‐Ju, Nin‐Chieh Hsu, Yu‐Feng Lin, et al.. (2021). Developing and validating a model for predicting 7-day mortality of patients admitted from the emergency department: an initial alarm score by a prospective prediction model study. BMJ Open. 11(1). e040837–e040837. 3 indexed citations
11.
Lin, Yu‐Feng, et al.. (2019). Typhoon Fanapi (2010) and its Interaction with Taiwan Terrain – Evaluation of the Uncertainty in Track, Intensity and Rainfall Simulations. Journal of the Meteorological Society of Japan Ser II. 98(1). 93–113. 6 indexed citations
12.
Lin, Yu‐Feng, et al.. (2019). Polydopamine-coated gold nanostar for combined antitumor and antiangiogenic therapy in multidrug-resistant breast cancer. Nanotheranostics. 3(3). 266–283. 44 indexed citations
13.
Huang, Tao‐Min, Vin‐Cent Wu, Yu‐Feng Lin, et al.. (2018). Effects of Statin Use in Advanced Chronic Kidney Disease Patients. Journal of Clinical Medicine. 7(9). 285–285. 12 indexed citations
14.
Liu, Ju‐Fang, Chiang‐Wen Lee, Ming-Horng Tsai, et al.. (2018). Thrombospondin 2 promotes tumor metastasis by inducing matrix metalloproteinase-13 production in lung cancer cells. Biochemical Pharmacology. 155. 537–546. 69 indexed citations
15.
Lin, Yu‐Feng. (2014). Typhoon Fanapi (2010) and its Interaction with Taiwan Terrain – Evaluation of the Uncertainty in Track and Rainfall Simulations. 1 indexed citations
16.
Hsu, Nin‐Chieh, Chin‐Chung Shu, Yu‐Feng Lin, et al.. (2012). Why do general medical patients have a lengthy wait in the emergency department before admission?. Journal of the Formosan Medical Association. 113(8). 557–561. 10 indexed citations
17.
Shu, Chin‐Chung, Jou‐Wei Lin, Yu‐Feng Lin, Nin‐Chieh Hsu, & Wen‐Je Ko. (2011). Evaluating the performance of a hospitalist system in Taiwan: A pioneer study for nationwide health insurance in Asia. Journal of Hospital Medicine. 6(7). 378–382. 33 indexed citations
18.
Lin, Yu‐Feng, Yung‐Ming Chen, Kuan‐Yu Hung, et al.. (2010). Benefits of Sevelamer on Markers of Bone Turnover in Taiwanese Hemodialysis Patients. Journal of the Formosan Medical Association. 109(9). 663–672. 13 indexed citations
19.
Lin, Yu‐Feng, Wen‐Je Ko, Vin‐Cent Wu, et al.. (2008). A Modified Sequential Organ Failure Assessment Score to Predict Hospital Mortality of Postoperative Acute Renal Failure Patients Requiring Renal Replacement Therapy. Blood Purification. 26(6). 547–554. 15 indexed citations
20.
Lin, Yu‐Feng, Ming‐Shiou Wu, Tzong‐Shinn Chu, et al.. (2008). Comparison of residual renal function in patients undergoing twice‐weekly versus three‐times‐weekly haemodialysis. Nephrology. 14(1). 59–64. 92 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ping Fu Breakdown of academic impact, for papers by Wen‐Feng Fang Breakdown of academic impact, for papers by Ying Yao Breakdown of academic impact, for papers by Vedat Schwenger Breakdown of academic impact, for papers by Raffaele Serra Breakdown of academic impact, for papers by Daniel Ackermann Breakdown of academic impact, for papers by John T. Harrington Breakdown of academic impact, for papers by Seung Seok Han Breakdown of academic impact, for papers by Mohammadreza Ardalan Breakdown of academic impact, for papers by Hye‐Ryun Kang
Rankless by CCL
2026